Stock Analysis

Natural Beauty Bio-Technology Full Year 2023 Earnings: HK$0.007 loss per share (vs HK$0.015 loss in FY 2022)

Published
SEHK:157
Source: Shutterstock

Natural Beauty Bio-Technology (HKG:157) Full Year 2023 Results

Key Financial Results

  • Revenue: HK$336.0m (flat on FY 2022).
  • Net loss: HK$15.1m (loss narrowed by 50% from FY 2022).
  • HK$0.007 loss per share (improved from HK$0.015 loss in FY 2022).
earnings-and-revenue-history
SEHK:157 Earnings and Revenue History February 25th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Natural Beauty Bio-Technology's share price is broadly unchanged from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Natural Beauty Bio-Technology that you should be aware of before investing here.

Valuation is complex, but we're helping make it simple.

Find out whether Natural Beauty Bio-Technology is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.